• 1
    Demedts M, Wells AU, Anto JM, et al. Interstitial lung diseases: An epidemiological overview. Eur Respir J. 2001;18(Suppl.): 216.
  • 2
    Coultas DB, Zumwalt RE, Black WC, Sobonya RE. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med. 1994;150: 967972.
  • 3
    Thomeer MJ, Costabel U, Rizzato G, et al. M. Comparison of registries of interstitial lung diseases in three European countries. Eur Respir J. 2001;18(Suppl.): 114118.
  • 4
    Lopez-Campos JL, Rodriguez-Becerra E. The Neumosur Task Group of the Registry of Interstitial Lung Diseases (RENIA). Incidence of interstitial lung diseases in the south of Spain 1998–2000: the RENIA study. Eur J Epidemiol. 2004;19: 155161.
  • 5
    Karakatsani A, Papakosta D, Rapti A, et al. Epidemiology of interstitial lung diseases in Greece. Respir Med. 2009;103: 11221129.
  • 6
    Gribbin J, Hubbard RB, Le Jeune I, et al. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax. 2006;61: 980985.
  • 7
    Von Plessen C, Grinde O, Gulsvik A. Incidence and prevalence of cryptogenic fibrosing alveolitis in a Norwegian community. Respir Med. 2003;97: 428435.
  • 8
    Raghu G, Weycker D, Edelsberg J, et al. G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006;174: 810816.
  • 9
    Perez ERF, Daniels CE, Schroeder DR, et al. Incidence, prevalence and clinical course of idiopathic pulmonary fibrosis; A population-based study. Chest. 2010;137: 129137.
  • 10
    Sutherland I, Mitchell DN, Hart PD. Incidence of intrathoracic sarcoidosis among young adults participating in a trial of tuberculosis vaccine. Br Med J. 1965;2: 497503.
  • 11
    Sartwell PE, Edwards LB. Epidemiology of sarcoidosis in the U.S. Navy. Am J Epidemiol. 1974;99: 250257.
  • 12
    Gorham ED, Garland C, Garland FC, et al. Trends and occupational associations in incidence of hospitalized pulmonary sarcoidosis and other lung diseases in Navy personnel. Chest. 2004;126: 14311438.
  • 13
    Reich JM, Johnson RE. Incidence of clinically identified sarcoidosis in a northwest United States population. Sarcoidosis Vasc Diffuse Lung Dis. 1996;13: 173177.
  • 14
    Byg KE, Milman N, Hansen S. Sarcoidosis in Denmark 1980–1994. A registry-based incidence study comprising 5536 patients. Sarcoidosis Vasc Diffuse Lung Dis. 2003;20: 4652.
  • 15
    Pietinalho A, Hiraga Y, Hosoda Y, et al. The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study. Sarcoidosis. 1995;12: 6167.
  • 16
    Musellim B, Kumbasar OO, Ongen G, et al. Epidemiological features of Turkish patients with sarcoidosis. Respir Med. 2009;103: 907912.
  • 17
    Schweisfurth H, Kieslich C, Satake N, et al. How are interstitial lung diseases diagnosed in Germany? Result of the scientific registry for the exploration of interstitial lung diseases (‘Fibrosis registry’) of the WALT. Pneumologie. 2003;57: 373382.
  • 18
    Raghu G, Collard HR, Egan JJ, et al. ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis. Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183: 788824.